These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia. Uciński WS; Naskalski JW Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916 [TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes. Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Grant PG; Colman RW Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810 [TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction. Taylor PM; Heptinstall S Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878 [No Abstract] [Full Text] [Related]
12. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets. Grant PG; Mannarino AF; Colman RW Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075 [TBL] [Abstract][Full Text] [Related]
13. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations? Wood PJ; Pao G; Ross G; Smith C Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425 [No Abstract] [Full Text] [Related]
14. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents. Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252 [No Abstract] [Full Text] [Related]
15. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes. Wedner HJ Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710 [TBL] [Abstract][Full Text] [Related]
17. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708 [TBL] [Abstract][Full Text] [Related]
18. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity. Nagasaka A; Hidaka H Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233 [TBL] [Abstract][Full Text] [Related]
19. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys]. Iwase K Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1678-91. PubMed ID: 6319206 [TBL] [Abstract][Full Text] [Related]
20. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Souness JE; Diocee BK; Martin W; Moodie SA Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]